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Abstract
We have isolated a novel variant of the Mel 1a melatonin receptor from an ovine PT cDNA library. Relative to the
reported sequence for the Mel 1a melatonin receptor there are 8 changes in the DNA sequence. Only 3 of these result in
amino acid substitutions, one in extracellular loop 3 and two in the carboxy-terminal tail. We have designated the novel
variant of the sheep Mel 1a receptor Mel 1a , and correspondingly the previously reported variant Mel 1a . As minorb a
changes in the primary amino acid sequence of G-protein-coupled receptors can influence their functional characteristics we
have accordingly characterized this novel variant of the Mel 1a melatonin receptor. This melatonin receptor displays high
affinity binding and inhibits the cAMP second messenger pathway in transfected L-cells demonstrating that this receptor is
fully functional. PCR analysis shows Mel 1a is present in several breeds of sheep and suggests that the Mel 1a receptorb b
was established early in the evolution of the sheep species. q1997 Elsevier Science B.V. All rights reserved.
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1. Introduction
Melatonin synthesis by the pineal gland occurs
only during the hours of darkness, and gates photope-
riodic information in mammals. This nocturnal mela-
tonin signal provides important information which
not only adjusts inherent circadian cycles to a 24-h
) Corresponding author. Fax: q44 01224 716653; E-mail:
pb@rri.sari.ac.uk
w xperiod 1,2 but also regulates reproductive and
metabolic parameters in seasonally responsive ani-
w xmals such as sheep and hamsters 3–5 .
Melatonin receptors have been cloned from a num-
ber of species including human, sheep, chicken, frog
w xand fish 6–9 . Structural and pharmacological data
currently define three subtypes of receptor Mel 1a, 1b
and 1c. Thus far only Mel 1a and 1b have been found
in mammalian species, but all three are found in
w xlower vertebrates 8,9 .
The melatonin receptor is a classical G-protein
0167-4889r97r$17.00 Copyright q 1997 Elsevier Science B.V. All rights reserved.
 .PII S0167-4889 96 00179-6
( )P. Barrett et al.rBiochimica et Biophysica Acta 1356 1997 299–307300
coupled receptor with seven transmembrane domains,
an extracellular N-terminal domain and three extra-
cellular loops. On the intracellular face of the plasma
membrane reside an intracellular carboxy-terminal
tail and three intracellular loops. The genomic struc-
ture of this receptor is composed of two exons sepa-
w xrated by a large intron 7 . Exon 1 encodes for the
extracellular N-terminal domain, transmembrane do-
main 1 and the first intracelluar loop. The remainder
of the receptor is contained within the second larger
exon.
 .In the cells of the pars tuberalis PT , the only
second messenger pathway firmly established to
which the melatonin receptor has been shown to
couple is an inhibition of the cAMP synthesis. How-
ever, recent studies have alluded to an additional
cAMP independent signal transduction mechanism
w xwhich mediates melatonin action 10 . In studies on
the regulation of the ovine melatonin receptor in PT
cells, a spontaneous increase in mRNA and protein
levels for the melatonin receptor were observed which
could be attenuated by the addition of melatonin to
the culture medium. The spontaneous increase in
mRNA and protein levels in PT cells was demon-
strated to occur in the absence of any change in
cAMP levels within PT cells. Furthermore, this spon-
taneous increase occurs in the absence of serum in
the culture media implicating an autoregulatory
mechanism of expression for the melatonin receptor
w x10 .
It is clear from work on other receptors, in particu-
lar the adrenergic receptor, that the transmembrane
and intracellular domains play an important role in
ligand binding, G-protein coupling, desensitization
and sequestration of G-protein-coupled receptors
w x11–17 . In such studies single amino acid changes
w xcan influence some of these functions 15–17 .
In this study we have isolated a novel variant of
the Mel 1a receptor from sheep. We have made a
functional analysis of this variant following stable
expression in L-cells, by ligand binding and cAMP
inhibition studies. We conclude that the amino acid
changes in this variant receptor do not alter the ligand
binding nor affect its ability to inhibit forskolin stim-
ulated cAMP generation. In addition this variant re-
ceptor is expressed in several breeds of sheep sug-
gesting that it originated at some early point in the
evolution of the sheep species.
2. Materials and methods
2.1. O˝ine PT Poly Aq RNA isolation and construc-
tion of a PT cDNA library.
Ovine PT’s were taken from sheep of mixed sex
and breed at a local abattoir and immediately frozen
on dry ice after removal from the animal. Poly Aq
RNA was isolated from 40 PTs using the Invitrogen
 .San Diego, CA, U.S.A. Fast Track mRNA isolation
system.
A randomly primed PT cDNA library was con-
structed in the vector l ZAP express using ZAP
express cloning kit and Stratagene’s random unidirec-
 .tional linker primer Stratagene, Cambridge, UK .
The Library was screened with a randomly primed
PCR fragment containing the ovine melatonin recep-
tor sequence from q406 to q935 Transmembrane 3
.to 7 at high stringency. Several positive clones were
isolated and sequenced using the Applied Biosystems
automated DNA sequencer.
The longest clone for the Mel 1a sequence wasb
45 bp short at the 5X-end of the coding sequence.
Therefore a full length clone was constructed by
replacing a Sac I restriction fragment containing the
short exon 1 region of this clone with a Sac I restric-
tion fragment containing the exon 1 region of another
clone obtained from the cDNA library. The correct
construct was confirmed by DNA sequence analysis.
2.2. PCR analysis
One microgram of PT poly Aq RNA was reverse
transcribed with random primers Promega,
.Southampton, UK and M-MuLV reverse transcrip-
 . w xtase Gibco, Paisley, UK as described 10 . Amplifi-
cation of the full length coding sequence was achieved
with specific primers PRM5-5X-AGCGCGATGGCG-
X  . XGGGCG-3 , y6 to q11 and C-tail 1- 5 -CCCC-
X  .CACGTTGTTTTCCTAGG-3 , q1176 to q1196
using one-tenth of the cDNA reaction and subject to
amplification over 35 cycles at 948C-1 min, 558C-1
min and 728C-1.5 min with 2.5 U Taq polymerase
 .Gibco, Paisley UK . To clone the amplified full
length sequence of Mel 1a , the PCR product wasb
purified by spin column chromatography over a
Chromaspin 400 column Clontech, Cambridge Bio-
.science, Cambridge, UK . The PCR product was
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ligated in to pGEM-T according to the manufacturer’s
 .instructions Promega, Southampton, UK . The se-
quence of exon 1 of Mel 1a was confirmed byb
automated DNA sequencing.
Ovine genomic DNA was extracted from whole
blood using a genomic DNA extraction kit Promega,
.Southampton U.K. . Approx. 100 ng of genomic
DNA was subject to amplification using the above
conditions but with specific primers Extloop2-5X-
X CGTGTAGGCTGAGCTGACGG-3 , q525 to
.  .q544 and C-tail 1 see above . One-tenth of the
PCR amplification reactions were subject to restric-
tion enzyme analysis with the enzymes Bfa 1 New
.  .England Biolabs, UK , Mae III Boeringher, UK ,
 .Apa I, Bam HI or Bst XI Promega . Products of
small molecular mass were resolved on a 2% Separide
 .agarose gel Gibco, Paisley, UK .
2.3. Transfection of L-cells
Mouse L-cells were transfected with the Mel 1ab
construct using Lipofectin transfection reagent as per
 .manufacturer’s instructions Gibco, Paisley, UK .
Two days after transfection, stable transfectants were
 .selected with G418 500 mgrml . Surviving colonies
were grown on and tested for expression of the
melatonin receptor using the ligand 125I-2-iodo-
 .  .melatonin I-Mel - 200 pM . One clone clone 63
expressing the melatonin receptor was subject to
further analysis.
2.4. Binding studies
L-cells were grown to 90% confluence in 90 mm
Petri dishes and recovered from the plate by scraping.
The cells were spun down at 1500=g for 5 min and
then frozen as whole cells at y708C until required.
For the binding assay the cells were thawed and
washed twice in binding buffer 10 mM Tris-HCl, pH
.7.5, 1 mM EGTA . Binding assays were carried out
in 96 well assay plates Millipore Multiscreen plates,
Millipore Corp. Milford, MA 0.22 mM polyvinyl-
. 5idene difluoride membrane . Aliquots of 2=10 cells
were incubated in a 200 ml volume in the presence of
100 pM I-Mel with varying concentrations of com-
petitor. For the saturation binding analysis the cells
were incubated with varying concentrations of I-Mel
up to 800 pM. The binding reaction was terminated
by vacuum filtration and washed three times with
ice-cold binding buffer. Data analysis was performed
using a computer-assisted ligand-binding programme
 .Grafit, Sigma, UK
2.5. cAMP analysis
L-cells stably transfected with the Mel 1a recep-b
tor cDNA were seeded into 24 well plates and grown
to sub-confluence. On the day of the experiment the
cells were washed with DMEM, 240 ml of DMEM
was added to each well and the plate placed in an
incubator 378C for 1 h. Drugs were then added in 60
ml at 5= final desired concentration, and the plates
incubated for a further 15 min at 378C. Incubations
were terminated by the addition of 100 ml TCA
 .20% to the culture medium or by removal of the
medium and addition of 400 ml of 5% TCA. Cyclic
w xAMP was measured as described previously 18 .
3. Results
Sequence analysis of a partial cDNA clone for the
Mel 1a melatonin receptor isolated from an ovine PT
cDNA library revealed a number of base changes in
the sequence compared to the sequence reported by
w xReppert et al. 7 . Of the eight base changes ob-
served, five occur at the third position in an amino
acid codon and are silent changes. However, one base
change occurs at the first position and two at the
second position of an amino acid codon. Thus these
changes also result in a substitution in the amino acid
sequence of the receptor protein at these positions
 .Table 1 . Within the topography of the melatonin
receptor protein, one of these changes occurs in the
third extracellular loop and two in the carboxy-termi-
nal tail. In the following text this variant of the Mel
1a receptor is referred to as the Mel 1a sequenceb
w xand that reported by Reppert et al. 7 is referred to as
Mel 1a .a
The partial cDNA clone was 45 bp short at the
5X-end of the sequence. A full length clone was
constructed through the replacement of a Sac I frag-
ment containing a portion of the vector and coding
sequence of the partial clone with a Sac I fragment
from a partial cDNA clone with a complete 5X-end
starting at y31, with respect to the first base of the
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Table 1
DNA sequence base changes and amino acid substitutions in the
ovine Mel 1a melatonin receptorb





q845 C“A Ala“Asp External loop 3
q1053 C“T None
q1073 A “G His“Arg C-terminal tail
q1081 A “G Ile“Val C-terminal tail
The position of the base change is given relative to the start of
the coding sequence. Relative to Mel 1a the base changes ata
positions q1073 and q1081 create restriction sites for the
enzymes Mae III and Bfa I, respectively.
.coding sequence . Using randomly primed reverse
transcribed PT mRNA, the sequence of the remaining
45 bp of the Mel 1a receptor was confirmed throughb
PCR amplification of the entire coding sequence plus
100 bp of the 3XUTR and ligation into the vector
pGEM-T for sequence analysis. The sequence of the
X 5 45 bp sequence of Mel 1a confirmed on bothb
.strands was identical to the sequence found in Mel
1a indicating that all the variations in the structurea
of Mel 1a sequence occur within exon 2 of the
melatonin receptor gene.
3.1. Expression studies
The Mel 1a receptor was stably transfected intob
mouse L-cells. Clones were selected on the basis of
G418 resistance and their ability to bind 125I-2-iodo-
 .melatonin I-Mel . One of the stably transfected
 .clones expressing the melatonin receptor clone 63
was analysed further in ligand binding studies and
cAMP second messenger signal transduction assays.
Clone 63 was found to express the receptor at a
 .density B of 81.9 fmolrmg protein and with amax
K of 203"20.7 pM. Binding was saturable andd
showed an approximate 50% reduction in the pres-
ence of GTPg S K s316"59.6 pM, B s49.8d max
.  .fmolrmg protein Fig. 1 . Competition binding anal-
ysis with several melatonin related compounds
demonstrated a pharmacological profile similar to the
Mel 1a receptor sequence with 2-iodoimelatonin)a
MelsS20098)6-hydroxyMelatonin)N-acetylse-
 .rotoninsLuzindol)5-methoxytryptophol Fig. 2a .
The slope values for these compounds in competition
125 to I-Mel are between 0.7 and 1 0.7–0.79 for
S20098, 2-iodomelatonin and N-acetylserotonin; 0.8–
0 .89 fo r m ela ton in , L uzindo l and 5-
.methoxytryptophol and 1 for 6-hydroxymelatonin ,
suggesting there may be some complexity in the
G-protein-receptor interaction at these levels of re-
ceptor expression, which has also been observed for
w xthe receptor in the native tissue 19 . A comparison of
K values for compounds common to this studyi
2-iodomelatonins109 pM, melatonins695 pM,
6-hydroxymelatonins8.6 nM and N-acetylserotonin
. w xs740 nM and that published by Reppert et al. 7
reveals a linear relationship between the values for
Fig. 1. Saturation binding analysis of the ovine Mel 1a receptorb
expressed in mouse L-cells. A. Specific binding data in the
 .  .presence v or absence of ‘ 100 mM GTPg S. B. Scatchard
 .  .plots of the saturation data in the presence v or absence ‘ of
100mM GTPg S. The calculated K value in the absence ord
presence of GTPg S is 203"20.7 pM and 316"59.6 pM respec-
tively. Data shown is the data of one representative experiment.
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Fig. 2. Competition binding experiments with the Mel 1a mela-b
tonin receptor expressed in mouse L-cells. A. Cells were incu-
bated at 378C for 2 h in the presence of 100 pM I-Mel and
various concentrations of competing ligands. The IC values50
obtained for these compounds were: 2-iodomelatonin 218 pM;
S20098, 0.912 nM; melatonin 1.39nM; 6-hydroxymelatonin 17.2
nM; Luzindol 1.28 mM N-acetylserotonin 1.48 mM; 5-metho-
xytryptophol 7.04 mM. B. K values for compounds used ini
common between this study for the Mel 1a receptor and thoseb
w xreported by Reppert et al. 7 for the Mel 1a receptor area
plotted. There is a linear relationship between the K values fori
these two receptors. Shown is the data from one representative
experiment.
 .both receptors Fig. 2b indicating that the changes
present in the Mel 1a sequence causes no majorb
differences in the ability to bind a limited number of
compounds.
Cyclic AMP signal transduction assays performed
with the stably transfected L-cells, show that this
receptor is able to inhibit forskolin stimulated cAMP
 .synthesis with a IC value of 3.49 nM Fig. 3 . Thus50
this Mel 1a sequence functions as far as we haveb
been able to determine in an identical manner to Mel
1a .a
3.2. PCR and restriction digestion analysis
The base changes at positions q1073 A“G and
q1081, A“G result in the introduction of restric-
tion sites for the enzymes Mae III and Bfa I, respec-
tively. Therefore the Mel 1a sequence could beb
distinguished from the Mel 1a sequence using thesea
two enzymes. Thus with the primers used in this
study a Mae III generated DNA fragment of 310 bp
found in the Mel 1a sequence q887 bp to q1196a
.bp will be cleaved into two fragments of 186 bp and
124 bp. Similarly, a Bfa I generated DNA fragment
of 293 bp found in the Mel 1a sequence q885 bpa
.to q1178 bp will be cleaved into two fragments of
194 bp and 99 bp for the Mel 1a sequence.b
Randomly primed cDNA generated from mRNA
isolated from PT’s of sheep of mixed sex and breed
was used in a PCR amplification with primers which
amplify the whole coding region or from extracellular
 .loop 2 q525 bp to a 100 bp within the
X  .3 UTR q1196 bp . When these amplified DNAs
were digested with either Bfa I or Mae III, DNA
restriction fragments diagnostic of both variants of
 .the melatonin receptor were observed Fig. 4a .
To address whether this receptor was a recent
polymorphism present in a restricted number of the
sheep PTs used for cDNA library construction, or an
allelic variant of the receptor which has been estab-
lished in the sheep species, PCR and restriction diges-
Fig. 3. Mel 1a inhibits forskolin stimulated cAMP synthesis inb
L-cells. Shown is the mean"SEM of five different experiments.
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Fig. 4. Mel 1a is present in several breeds of sheep and is expressed in the ovine PT. A. PCR and restriction digestion analysis usingb
randomly primed PT cDNA from sheep of mixed breed and sex. PCR primers were designed to amplify a region from the second
extracellular loop of the receptor to a 100 bp beyond the stop codon. The resultant product was digested with the restriction enzyme
MaeIII and the products were separated on a 2% Separide agarose gel. Mae III generates products of 310, 139, 127 and 95 bp for the Mel
1a and 186, 139, 127, 124 and 95 bp for Mel 1a . Bfa1 will generate products of 359 and 293 bp for Mel 1a and 359, 194 and 99 bpa b a
for Mel 1a . Lane 1: Bfa I digested PCR products. Lane 2: Mae III digested PCR products. B. Analysis of ovine genomic DNA by PCRb
and restriction digestion. A PCR product of 671 bp was amplified using primers Extloop 2 and C-tail 1. The products were subjected to
digestion with the enzymes Mae III or Bfa I. Shown are the results of the analysis for the Greyface=Dorset cross genomic DNA. The
individual sheep are identified by the number indicated below each lane.
tion analysis was performed on genomic DNA iso-
lated from three different breeds of sheep. PCR am-
plification was performed with primers amplifying a
region from the second extracellular loop to a 100 bp
X beyond the stop codon in the 3 UTR q525 bp to
.q1196 bp . The resultant DNA fragments were sub-
jected to digestion with either Bfa I or Mae III. Of
the six Greyface=Suffolk cross, four were found to
be homozygous for the Mel 1a receptor and twoa
were heterozygous for both forms of the receptor. Of
six pure bred Soay rams analysed, three were ho-
mozygous for Mel 1a , and three were heterozygousa
for both Mel 1a and Mel 1a . Genomic DNAa b
analysed from six Greyface=Dorset cross, two were
homozygous for Mel 1a , three were heterozygousa
for both forms of the receptor and one was homozy-
 .gous for the Mel 1a receptor Fig. 4b . Restrictionb
digestion analysis was also performed with enzymes
Apa I, Bam HI and Bst XI to ensure there were no
major changes in the base sequence of the amplified
DNA due to Taq polymerase. All amplified frag-
ments cleaved completely with these enzymes as
expected from the sequence analysis of both forms of
 .the receptor data not shown . In all cases there was
no occurrence of the additional MaeIII restriction site
without the presence of the additional Bfa I restric-
tion site. An additional possibility is that there are
two independent copies of the gene present in the
ovine genome. However, Southern blot analysis using
a number of different restriction enzymes suggests
there is only one copy of the Mel 1a sequence per
 .haploid genome data not shown . Thus the Mel 1ab
sequence is present in a range of breeds of sheep
including a pure bred Soay line.
4. Discussion
From a sequence analysis of a clone for an ovine
Mel 1a melatonin receptor isolated from our PT
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cDNA library, we have observed eight base changes
for the sequence of this receptor when compared to
w xthe sequence reported by Reppert et al. 7 . The
melatonin receptor gene sequence is organized within
the genome as two exons separated by a large intron
w x7 . The changes we have observed in the base se-
quence of the Mel 1a receptor all occur in the larger
exon 2 of the receptor sequence. Five of these changes
are in the third position of an amino acid codon and
result in no change of the amino acid sequence at
these points in the receptor structure. However, three
sequence changes are present at either the first or
second positions of the codons and result in amino
acid substitutions. One substitution occurs in the third
extracellular loop where there is a non-conservative
change of an alanine for an aspartate residue. Two
other substitutions are in the carboxy-terminal tail,
one conservative change of an isoleucine by a valine
residue and a non-conservative change of an histidine
residue by an arginine residue. Potentially the non-
conservative changes could cause local perturbations
to the three dimensional structure of the receptor and
alter some of the receptor characteristics. Recent
studies involving the adrenergic receptors suggest
that the carboxy-terminal tail of these receptors is
involved in desensitization and sequestration, largely,
but perhaps not entirely due to phosphorylation of
serine and threonine residues by the adrenergic recep-
w xtor kinase bARK 20 . However, residues other than
serine and threonine may be important as suggested
by a recent report which demonstrated that the substi-
tution of a tyrosine residue at the interface between
transmembrane domain 7 and the carboxy-terminal
tail of the b 2 adrenergic receptor abrogates seques-
tration and may be a specific determinant for this
w xprocess 15 .
Mutations in the intracellular and extracellular
loops of a number of G-protein-coupled receptors,
w xhave been shown to alter receptor functions 16 . In
particular a single amino acid substitution in the first
extracellular loop of the mouse Melanocyte stimulat-
 so .ing hormone receptor Leu“Pro, E mutation
which probably partially activates the receptor, gives
rise to mice with a darker coat colour when they are
w xhomoyzgous for the mutant receptor 17 . The impor-
tance of the extracellular loops and their three dimen-
sional structure is further highlighted by antibodies
which interact with these regions. Several antibodies,
including those found in autoimmune diseases are
known to activate G-protein-coupled receptors, prob-
ably by stabilizing the ‘active state’ conformation of
w xthe receptor 21,22 .
Thus it was important to establish whether these
changes in the Mel 1a sequence altered the bindingb
characteristics or signal transduction properties of the
receptor. In this respect we found no dramatic change
in the ability of the variant Mel 1a receptor to bindb
to melatonin and related compounds and this receptor
was fully functional in inhibiting forskolin generated
cAMP synthesis in L-cells. However, relative to the
w xdata reported for Mel 1a by Reppert et al. 7 , thea
affinities in terms of I-Mel binding and melatonin
displacement appear to be 6 times lower for Mel 1a .b
Consistent with this the inhibition of forskolin-
stimulated cyclic AMP was of slightly reduced po-
w xtency relative to that reported for Mel 1a 7 . How-a
ever, these are relatively minor differences which are
likely to reflect differences in methodologies between
the two studies, in particular a difference between the
cells used as transfection vehicles for the recombi-
nant receptor expression.
I-Mel ligand binding analysis using isolated PT
membranes in the presence of increasing concentra-
tions of GTPg S results in a reduction of specific
I-Mel binding by up to 50% at the maximal effective
dose of 100 mM GTPg S. This is in contrast to the
chicken brain membrane preparations where greater
reductions in I-Mel binding in the presence of GTPg S
w xare observed 23 . The ability to achieve only a 50%
reduction in I-Mel binding in the presence of GTPg S
could be accounted for by the presence of two mela-
tonin receptors which are differentially responsive to
GTPg S. One possibility therefore is the Mel 1ab
receptor could constitute either the 50% of receptor
binding I-Mel which is unresponsive to GTPg S, or
may be the 50% of receptor binding I-Mel that is
responsive to GTPg S. However neither of these pos-
sibilities is likely to be the case as the GTPg S
sensitivity of this receptor expressed in L-cells is
approx. 50% as found in PT cells. Furthermore the
solubilized receptor complex isolated from L-cells
and Cos 7 cells has the same molecular mass as the
solubilized complex isolated from PT cell membranes
 . w x;525kDa 24 and suggests the receptor expressed
in a heterologous cell line is able to form a similar
 .complex as observed in the PT data not shown .
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Thus as far as we have been able to determine this
Mel 1a receptor is functionally similar to the Melb
w x1a sequence reported earlier 7 . However, it shoulda
be noted that although we have been unable to detect
any changes in the functioning of this receptor using
the assays available to us, these changes, particularly
in the carboxy-terminal tail could have consequences
for aspects of receptor functioning that we are so far
unable to assay, for example, desensitization and
sequestration for which no information is available
for the Mel 1a receptor.
PCR and restriction enzyme digestion analysis re-
vealed the expression of the Mel 1a sequence in theb
ovine PT where most likely it functions as a bona
fide melatonin receptor. This is supported by the
observation that in the analysis carried out with three
independent PT cDNA samples, the restriction frag-
ments diagnostic of Mel 1a were well represented orb
even in the majority for the both forms of the mela-
 .tonin receptor Fig. 4a . Genomic DNA analysis
demonstrate the Mel 1a sequence is present inb
several breeds of sheep including a pure bred Soay.
The Soay sheep is one of the oldest breeds of sheep
in Britain, introduced around 3000BC by our Ne-
w xolithic ancestors 25 . Thus it would appear that
mutations in the Mel 1a sequence arose and became
established at some early point in the evolution of the
sheep species. We have found Mel 1a to be effi-b
ciently expressed in the PT, however, in the genomic
DNA of 18 sheep we have analysed we have found
only one of the individuals to be homozygous for
Mel 1a and eight to be heterozygous for Mel 1ab a
and 1a . Therefore, the possibility may exist that Melb
1a is transcribed in preference to Mel 1a . How-b a
ever, to firmly establish this point, individual PT
samples together with the corresponding genomic
DNAs would need to be analysed.
In all of the PCR generated DNA fragments ampli-
fied from genomic DNA, there was no occurrence of
the additional MaeIII restriction site without the pres-
ence of the additional Bfa I restriction site. The
presence of one of the additional restriction sites
without the other is of course possible if an homolo-
gous crossover event took place between the two
restriction sites during meiosis. However as the two
additional restriction sites are separated by 7 bp, the
possibility of this taking place is small. As the other
base changes in the receptor sequence are further
apart, the chances of finding cDNA clones containing
various combinations of these changes increases.
As we have demonstrated, polymorphisms in the
ovine Mel 1a receptor exist. Similar mutations may
also occur in either the Mel 1a, 1b or 1c subtypes in
other species. If similar mutations do exist, there is
the possibility that the changes in amino acid se-
quence that could potentially occur may either inacti-
vate or constituitively activate the receptor and there-
fore have consequences on the biochemistry of mela-
tonin responsive cells.
Acknowledgements
We would like to thank Clare Adam, Pat Findley
and Raymond Aitken for the sheep blood. April
Newman for assistance with the DNA sequence anal-
ysis. Also for technical assistance, Alison MacLean,
Marie Morris and Sarah Canning. This work was
supported by SOAEFD.
References
w x  .1 Armstrong, S.M. 1989 Experientia 45, 932–938.
w x  .2 Cassone, V.M. 1990 Trends Neurosci 13, 457–464.
w x  .3 Hoffman, K. 1973 J. Comp. Physiol. 85, 267–282.
w x  .4 Carter D.S. and Goldman, B.D. 1983 Endocrinol. 113,
1261–1267.
w x  .5 Wayne, N.L., Malpaux, B., and Karsch, F.J. 1988 Biol
Reprod. 39, 66–75.
w x6 Ebisawa., T., Karne, S., Lerner, M.R. and Reppert, S.M.
 .1994 Proc. Natl. Acad. Sci. 91, 6133–6137.
w x  .7 Reppert, S.M., Weaver, D.R. and Ebisawa, T. 1994 Neu-
ron 13, 1177–1185.
w x8 Reppert, S.M., Weaver, D.R., Cassone, V.M., Godson, C.
 .and Kolakowski, Jr. L.F. 1995 Neuron 15, 1003–1015.
w x9 Liu, F., Yuan, H., Sugamori, K.S., Hamadanizadeh, A., Lee,
F.J.S., Pang, S.F., Brown, G.M., Pristupa, Z.B. and Niznik,
 .H.B. 1995 FEBS lett. 374, 273–278.
w x10 Barrett, P., MacLean, A., Davidson, G. and Morgan, P.J.
 .1996 Mol. Endocrinol. 10, 892–902.
w x11 Strader, C.D., Fong, T.M., Tota, M.R., Underwood, D. and
 .Dixon, R.A.F. 1994 Ann. Rev. Biochem. 63, 101–132.
w x12 Barak, L.S., Menard, L., Ferguson, S.S.G., Colapietro, A.M.´
 .and Caron, M.G. 1995 Biochem. 34, 15407–15414.
w x  .13 Rousseau, G., Nantel, F. and Bouvier, M. 1996 Mol.
Pharmacol. 49, 752–760.
w x14 Jockers, R., Da Silva, A. Strosberg, A. D., Bouvier, M. and
 .Marullo, S. 1996 J. Biol. Chem. 271, 9355–9362.
( )P. Barrett et al.rBiochimica et Biophysica Acta 1356 1997 299–307 307
w x15 Barak, L.S., Tiberi, M., Friedman, N.J., Kwatra, M.M.,
 .Lefkowitz, R.J. and Caron, M.G. 1994 J. Biol. Chem. 269,
2790–2795.
w x  .16 Birnbaumer, M. 1995 J. Recep. Signal Trans. Res. 15,
131–160.
w x17 Robbins, L.S., Nadeau, J.H., Johnson, K. R., Kelly, M.A.,
Roselli–Rehfuss, L., Baack, E., Mountjoy, K.G. and Cone,
 .R.D. 1993 Cell 72, 827–834.
w x  .18 Morgan PJ, Davidson G, Lawson W and Barrett P 1990 . J.
Neuroendocrinol. 2, 773–776.
w x19 Howell, H.E., Gaurdiola, B., Renard, P. and Morgan, P.J.
 .1994 Endocrine 2, 979–988.
w x  .20 Strosberg, A.D. 1993 Protein Sci. 2, 1198–1209.
w x21 Fu, M.L.X., Herlitz, H., Wallukat, G., Hilme, E., Hedner,
 .T., Hoebeke, J. and Hjamarson, A. 1994 Lancet 344,
1660–1664.
w x22 Alla, S.A., Quitterer, U., Grigoriev, S., Maidhof, A., Hasse-
 .mann, M., Jarnagin, K. and Muller-Esterl, W. 1996 J.
Biol. Chem. 271, 1748–1755.
w x23 Morgan, P.J., Williams, L.M., Barrett, P., Lawson, W.,
 .Davidson, G. Hannah, L. and MacLean, A. 1996 Neu-
rochem. Int. 28, 259–269.
w x  .24 Barrett, P., MacLean, A. and Morgan, P.J. 1994 Neuroen-
docrinol. 6, 509–515.
w x  .25 Doney, J.N., Ryder, N.L., Gunn, R.G. and Grubb, P. 1974
In Island survivors: The ecology of the Soay sheep of St
Kilda. Eds. Jewell, P.A., Milner, C. and Boyd, J.H., Athlone
Press, London.
